Preview

Russian Journal of Transplantology and Artificial Organs

Advanced search

On the possibility of therapeutic action after transdermal patch application

https://doi.org/10.15825/1995-1191-2022-2-119-124

Abstract

Background. As scientific knowledge about the peculiarities of the structure and functional properties of the skin increased, it became clearer that during transdermal administration, drug may accumulate in the deep layers of the dermis and subsequently get diffused into the bloodstream even after the transdermal therapeutic system (TTS), also called transdermal patch, had been removed. Objective: to quantify active drug substances remaining in an animal skin after TTS application. Materials and methods. Two previously developed transdermal patches containing Russian-made drug substances were chosen for the study: aminodihydrophthalazinedione sodium (immunomodulator) and bis(1-vinylimidazole-N) zinc diacetate (antidote for carbon monoxide). The study was performed on male Chinchilla rabbits weighing 2.5–3 kg. Five series of experiments were performed for each substance: immediately after removal of the patch, 4 hours later, at week 1, 2 and 3 after removal. High-performance liquid chromatography and atomic absorption spectroscopy methods were used to quantify residual drug substances left in the skin. Results. In the skin flap that was in contact with the aminodihydrophthalazinedione sodium TTS for 24 hours, 0.516 mg of the drug was detected immediately after removal of the patch. Over the next two weeks, the drug substance in the skin decreased with the immunomodulator significantly reducing to 0.41 mg in the first 4 hours. In the skin flap that had been in contact with zinc bis(1-vinylimidazole-N) diacetate for 24 hours, about 1 mg of the drug was present immediately after patch removal. Four hours after removal of the transdermal patch, the quantity of active substance in the skin remained practically unchanged. At week 1 and 2, the quantity of the antidote decreased slightly to ~0.7 mg and ~0.25 mg, respectively. Conclusion. For transdermal application of aminodihydrophthalazinedione sodium, the skin can act as a drug depot and prolong the effect of this drug even after the transdermal patch had been removed. No such effect was found in the case of bis(1-vinylimidazole-N) zinc diacetate, which is apparently due to the different solubility of the drugs in the biotissue.

About the Authors

E. G. Kuznetsova
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation

Evgeniya Kuznetsova

1, Shchukinskaya str., Moscow, 123182
Phone: (499) 196-26-61



O. M. Kuryleva
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation

Moscow



L. A. Salomatina
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation

Moscow



S. V. Kursakov
Institute of Biomedical Science and Technology
Russian Federation

Moscow



V. Yu. Belov
Shumakov National Medical Research Center of Transplantology and Artificial Organs; Institute of Biomedical Science and Technology
Russian Federation

Moscow



Z. Z. Gonikova
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation

Moscow



Yu. B. Basok
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation

Moscow



V. I. Sevastianov
Shumakov National Medical Research Center of Transplantology and Artificial Organs
Russian Federation

Moscow



References

1. Varpahovskaya I. Novye sistemy dostavki lekarstvennyh sredstv. Remedium. 1999; 2: 62–70.

2. Losenkova SO. Transdermal’nye terapevticheskie sistemy. Eksperimental’naya i klinicheskaya farmakologiya. 2008; 71 (6): 54–57. doi: 10.30906/0869-2092-2008-71-6-54-57.

3. Savva N. Fentanil i fentanilovyj plastyr’ v palliativnoj praktike detskogo obezbolivaniya [opublikovano 31 avgusta 2018]. Dostopno: https://pro-palliativ.ru/blog/fentanil-i-fentanilovyj-plastyr-v-palliativnoj-praktike-detskogo-obezbolivaniya.

4. Sevast’yanov VI, Salomatina LA, Kuznecova EG, Seregina MV, Basok YB. Transdermal’naya lekarstvennaya forma acizola – antidota ugarnogo gaza. Perspektivnye materialy. 2008; 6: 55–59.

5. Kuznecova EG, Kuryleva OM, Salomatina LA, Sevast’janov VI. Jeksperimental’noe issledovanie diffuzii immunomoduljatora Galavit ® v model’noj sisteme. Razrabotka i registracija lekarstvennyh sredstv. 2020; 9 (1): 92–97. [In Russ, English abstract]. doi: 10.33380/2305-2066-2020-9-1-92-97.

6. El Maghrabya GM, Barryc BW, Williamsd AC. Liposomes and skin: From drug delivery to model membranes. European journal of pharmaceutical sciences. 2008; 34: 203–222. doi: 10.1016/j.ejps.2008.05.002.

7. Kuznecova EG, Kuryleva OM, Salomatina LA, Kursakov SV, Gonikova ZZ, Nikol’skaya AO, Sevast’yanov VI. Sravnitel’nyj analiz farmakokineticheskih parametrov transdermal’nogo i vnutrimyshechnogo vvedenij preparata Galavit® . Vestnik transplantologii i iskusstvennyh organov. 2021; 23 (2): 114–121. [In Russ, English abstract]. doi: 10.15825/1995-1191-2021-2-114-121.

8. Galavit® (Galavit): instrukciya po primeneniyu. Spravochnik lekarstvennyh sredstv Vidal. Dostupno: https://www.vidal.ru/drugs/galavit__44378.

9. Acizol® (Acyzol): instrukciya po primeneniyu. Spravochnik lekarstvennyh sredstv Vidal. Dostupno: https://www.vidal.ru/drugs/acyzol__28650.


Review

For citations:


Kuznetsova E.G., Kuryleva O.M., Salomatina L.A., Kursakov S.V., Belov V.Yu., Gonikova Z.Z., Basok Yu.B., Sevastianov V.I. On the possibility of therapeutic action after transdermal patch application. Russian Journal of Transplantology and Artificial Organs. 2022;24(2):119-124. https://doi.org/10.15825/1995-1191-2022-2-119-124

Views: 395


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)